دورية أكاديمية

Co-Targeting of BTK and TrxR as a Therapeutic Approach to the Treatment of Lymphoma

التفاصيل البيبلوغرافية
العنوان: Co-Targeting of BTK and TrxR as a Therapeutic Approach to the Treatment of Lymphoma
المؤلفون: Sicong Wang, Erin Clapper, Kathryn F. Tonissen, Giovanna Di Trapani
المصدر: Antioxidants, Vol 12, Iss 2, p 529 (2023)
بيانات النشر: MDPI AG
سنة النشر: 2023
المجموعة: Directory of Open Access Journals: DOAJ Articles
مصطلحات موضوعية: thioredoxin reductase, bruton’s tyrosine kinase, B-cell receptor signaling pathway, DLBCL, Therapeutics. Pharmacology, RM1-950
الوصف: Diffuse large B-cell lymphoma (DLBCL) is a haematological malignancy representing the most diagnosed non-Hodgkin’s lymphoma (NHL) subtype. Despite the approved chemotherapies available in clinics, some patients still suffer from side effects and relapsed disease. Recently, studies have reported the role of the Trx system and the BCR signalling pathway in cancer development and drug resistance. In this regard, we assessed a potential link between the two systems and evaluated the effects of [Au(d2pype) 2 ]Cl (TrxR inhibitor) and ibrutinib (BTK inhibitor) alone and in combination on the cell growth of two DLBCL lymphoma cell lines, SUDHL2 and SUDHL4. In this study, we show higher expression levels of the Trx system and BCR signalling pathway in the DLBCL patient samples compared to the healthy samples. The knockdown of TrxR using siRNA reduced BTK mRNA and protein expression. A combination treatment with [Au(d2pype) 2 ]Cl and ibrutinib had a synergistic effect on the inhibition of lymphoma cell proliferation, the activation of apoptosis, and, depending on lymphoma cell subtype, ferroptosis. Decreased BTK expression and the cytoplasmic accumulation of p65 were observed after the combination treatment in the DLBCL cells, indicating the inhibition of the NF-κB pathway. Thus, the co-targeting of BTK and TrxR may be an effective therapeutic strategy to consider for DLBCL treatment.
نوع الوثيقة: article in journal/newspaper
اللغة: English
تدمد: 2076-3921
العلاقة: https://www.mdpi.com/2076-3921/12/2/529Test; https://doaj.org/toc/2076-3921Test; https://doaj.org/article/4b396097c98a40f3b50d2fc5f0f31990Test
DOI: 10.3390/antiox12020529
الإتاحة: https://doi.org/10.3390/antiox12020529Test
https://doaj.org/article/4b396097c98a40f3b50d2fc5f0f31990Test
رقم الانضمام: edsbas.6632A0C9
قاعدة البيانات: BASE
الوصف
تدمد:20763921
DOI:10.3390/antiox12020529